{"id":57640,"date":"2023-06-23T19:04:41","date_gmt":"2023-06-23T17:04:41","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\/"},"modified":"2023-06-23T19:04:41","modified_gmt":"2023-06-23T17:04:41","slug":"ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\/","title":{"rendered":"GE HealthCare Announces Cash Dividend for Second Quarter of Fiscal Year 2023"},"content":{"rendered":"<div>\n<p>CHICAGO&#8211;(BUSINESS WIRE)&#8211;The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC), a leading medical technology, pharmaceutical diagnostics, and digital solutions innovator, today declared a cash dividend of $0.03 per share of Common Stock for the second quarter of 2023 payable on August 15, 2023 to all shareholders of record as of July 21, 2023.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230623933856\/en\/1673594\/5\/GE_HealthCare_Logo_%28Jan_2023%29.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230623933856\/en\/1673594\/21\/GE_HealthCare_Logo_%28Jan_2023%29.jpg\"><\/a><\/p>\n<p>\n<b>About GE HealthCare<\/b>\n<\/p>\n<p>\nGE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient\u2019s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are an $18.3 billion business with 50,000 employees working to create a world where healthcare has no limits.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investor Relations Contact:<\/b><br \/>Carolynne Borders<br \/>\n<br \/>+1-631-662-4317<br \/>\n<br \/><a target=\"_blank\" href=\"ma&#105;&#108;&#116;&#x6f;&#x3a;&#x63;&#x61;&#x72;ol&#121;&#110;&#110;&#x65;&#x2e;&#x62;&#x6f;&#x72;de&#114;&#115;&#64;&#x67;&#x65;&#x68;&#x65;&#x61;lt&#104;&#99;&#97;&#x72;&#x65;&#x2e;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#99;&#x61;r&#111;&#x6c;y&#110;&#x6e;e&#46;&#x62;o&#114;&#x64;e&#114;&#x73;&#64;&#103;&#x65;h&#101;&#x61;l&#116;&#x68;c&#97;&#x72;e&#46;&#x63;o&#x6d;<\/a>\n<\/p>\n<p>\n<b>Media Contact:<\/b><br \/>Tor Constantino<br \/>\n<br \/>+1-585-441-1658<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#x69;&#x6c;t&#x6f;&#58;t&#x6f;&#114;&#46;&#x63;&#111;&#x6e;&#x73;t&#x61;&#110;t&#x69;&#110;o&#x40;&#103;&#x65;&#x68;&#101;&#x61;&#x6c;t&#x68;&#99;a&#x72;&#101;&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x74;&#x6f;&#x72;&#46;&#99;on&#x73;&#x74;&#x61;&#110;&#116;in&#x6f;&#x40;&#x67;&#101;&#104;ea&#x6c;&#x74;&#x68;&#99;&#97;re&#x2e;&#x63;&#x6f;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHICAGO&#8211;(BUSINESS WIRE)&#8211;The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC), a leading medical technology, pharmaceutical diagnostics, and digital solutions innovator, today declared a cash dividend of $0.03 per share of Common Stock for the second quarter of 2023 payable on August 15, 2023 to all shareholders of record as of July 21, 2023. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-57640","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GE HealthCare Announces Cash Dividend for Second Quarter of Fiscal Year 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GE HealthCare Announces Cash Dividend for Second Quarter of Fiscal Year 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHICAGO&#8211;(BUSINESS WIRE)&#8211;The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC), a leading medical technology, pharmaceutical diagnostics, and digital solutions innovator, today declared a cash dividend of $0.03 per share of Common Stock for the second quarter of 2023 payable on August 15, 2023 to all shareholders of record as of July 21, 2023. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-23T17:04:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230623933856\/en\/1673594\/21\/GE_HealthCare_Logo_%28Jan_2023%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"GE HealthCare Announces Cash Dividend for Second Quarter of Fiscal Year 2023\",\"datePublished\":\"2023-06-23T17:04:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\\\/\"},\"wordCount\":193,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230623933856\\\/en\\\/1673594\\\/21\\\/GE_HealthCare_Logo_%28Jan_2023%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\\\/\",\"name\":\"GE HealthCare Announces Cash Dividend for Second Quarter of Fiscal Year 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230623933856\\\/en\\\/1673594\\\/21\\\/GE_HealthCare_Logo_%28Jan_2023%29.jpg\",\"datePublished\":\"2023-06-23T17:04:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230623933856\\\/en\\\/1673594\\\/21\\\/GE_HealthCare_Logo_%28Jan_2023%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230623933856\\\/en\\\/1673594\\\/21\\\/GE_HealthCare_Logo_%28Jan_2023%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GE HealthCare Announces Cash Dividend for Second Quarter of Fiscal Year 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GE HealthCare Announces Cash Dividend for Second Quarter of Fiscal Year 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\/","og_locale":"en_US","og_type":"article","og_title":"GE HealthCare Announces Cash Dividend for Second Quarter of Fiscal Year 2023 - Pharma Trend","og_description":"CHICAGO&#8211;(BUSINESS WIRE)&#8211;The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC), a leading medical technology, pharmaceutical diagnostics, and digital solutions innovator, today declared a cash dividend of $0.03 per share of Common Stock for the second quarter of 2023 payable on August 15, 2023 to all shareholders of record as of July 21, 2023. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-06-23T17:04:41+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230623933856\/en\/1673594\/21\/GE_HealthCare_Logo_%28Jan_2023%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"GE HealthCare Announces Cash Dividend for Second Quarter of Fiscal Year 2023","datePublished":"2023-06-23T17:04:41+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\/"},"wordCount":193,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230623933856\/en\/1673594\/21\/GE_HealthCare_Logo_%28Jan_2023%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\/","url":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\/","name":"GE HealthCare Announces Cash Dividend for Second Quarter of Fiscal Year 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230623933856\/en\/1673594\/21\/GE_HealthCare_Logo_%28Jan_2023%29.jpg","datePublished":"2023-06-23T17:04:41+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230623933856\/en\/1673594\/21\/GE_HealthCare_Logo_%28Jan_2023%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230623933856\/en\/1673594\/21\/GE_HealthCare_Logo_%28Jan_2023%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"GE HealthCare Announces Cash Dividend for Second Quarter of Fiscal Year 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/57640","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=57640"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/57640\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=57640"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=57640"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=57640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}